Outperforming ETF manager names a potential -2-
These total returns are all through March 28 and are after expenses and include reinvested dividends:
ETF or mutual fund Ticker Oct. 8, 2021, through March 28, 2024 1 year 3 years 5 years 10 years Simplify Health Care ETF PINK 26.0% 26.7% N/A N/A N/A Fidelity MSCI Health Care Index ETF FHLC 13.8% 17.4% 23% 70% 195% T. Rowe Price Health Sciences Fund, Class I THISX 1.4% 16.0% 13% 64% 210% Fidelity Select Health Care Portfolio FSPHX 0.9% 12.2% 7% 61% 177% Health Care Select Sector SPDR ETF XLV 21.0% 18.2% 32% 78% 201% SPDR S&P 500 ETF Trust SPY 24.1% 34.1% 38% 102% 238%
For the T. Rowe Price Health Sciences Fund, the 10-year performance figure is for the Investor Class shares PRHSX, because the Class I shares were first made available in 2016.
Click on the tickers for more about any company or fund.
Click here for Tomi Kilgore's detailed guide to the wealth of information available for free on the MarketWatch quote page.
Don't miss: Here's how Wall Street analysts' favorite stock picks performed over the past five years
-Philip van Doorn
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
04-06-24 0711ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Amazon Earnings: AWS Growth Accelerates and Profit Margins Improve
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?